Literature DB >> 10189844

Bromelain protects piglets from diarrhoea caused by oral challenge with K88 positive enterotoxigenic Escherichia coli.

D S Chandler1, T L Mynott.   

Abstract

BACKGROUND: K88 positive enterotoxigenic Escherichia coli (K88+ ETEC) is an important cause of diarrhoea in young piglets. K88+ ETEC pathogenesis relies on attachment to specific glycoprotein receptors located on the intestinal mucosa. Proteolytic treatment of these receptors in vitro and in vivo prevents attachment of K88+ ETEC to piglet small intestines and may be of clinical use to prevent K88+ ETEC pathogenesis. AIMS: To determine whether bromelain, a proteolytic extract obtained from pineapple stems, would protect piglets against K88+ ETEC diarrhoea and to confirm and extend earlier findings on the effects of bromelain on K88+ ETEC receptors in vivo.
METHODS: Bromelain (0, 12.5, or 125 mg) was orally administered to just weaned piglets for 10 days. One day following commencement of bromelain treatment, piglets were challenged with K88+ ETEC (5 x 10(10) K88ac:0149) for seven days. Intestinal contents from unchallenged piglets were obtained via an intestinal fistula, and tested for their ability to bind K88+ ETEC before and after bromelain treatment.
RESULTS: Both doses of bromelain were successful in reducing the incidence of K88+ ETEC diarrhoea and protected piglets from life threatening disease. Bromelain treated pigs also had significantly increased weight gain compared with untreated pigs. Bromelain only temporarily inhibited K88+ ETEC receptor activity, with receptor activity being regenerated 30 hours following treatment, consistent with the regeneration of new enterocytes.
CONCLUSION: Results show that bromelain can temporarily inactivate ETEC receptors in vivo and protect against ETEC induced diarrhoea. Bromelain may therefore be an effective prophylaxis against ETEC infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10189844      PMCID: PMC1727222          DOI: 10.1136/gut.43.2.196

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  14 in total

1.  A genetic basis for resistance to enteric disease caused by E. coli.

Authors:  J M Rutter; M R Burrows; R Sellwood; R A Gibbons
Journal:  Nature       Date:  1975-09-11       Impact factor: 49.962

Review 2.  Host-specific fimbrial adhesins of noninvasive enterotoxigenic Escherichia coli strains.

Authors:  W Gaastra; F K de Graaf
Journal:  Microbiol Rev       Date:  1982-06

3.  Adhesion of enteropathogenic Escherichia coli to pig intestinal brush borders: the existence of two pig phenotypes.

Authors:  R Sellwood; R A Gibbons; G W Jones; J M Rutter
Journal:  J Med Microbiol       Date:  1975-08       Impact factor: 2.472

4.  Role of the K88 antigen in the pathogenesis of neonatal diarrhea caused by Escherichia coli in piglets.

Authors:  G W Jones; J M Rutter
Journal:  Infect Immun       Date:  1972-12       Impact factor: 3.441

5.  Age-specific colonization of porcine intestinal epithelium by 987P-piliated enterotoxigenic Escherichia coli.

Authors:  E A Dean; S C Whipp; H W Moon
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

6.  Bromelain prevents secretion caused by Vibrio cholerae and Escherichia coli enterotoxins in rabbit ileum in vitro.

Authors:  T L Mynott; S Guandalini; F Raimondi; A Fasano
Journal:  Gastroenterology       Date:  1997-07       Impact factor: 22.682

7.  Soluble pig intestinal cell membrane components with affinities for E. coli K88+ antigen.

Authors:  T E Staley; I B Wilson
Journal:  Mol Cell Biochem       Date:  1983       Impact factor: 3.396

8.  Screening of pig intestines for K88 non-adhesive phenotype by enzyme immunoassay.

Authors:  D S Chandler; H M Chandler; R K Luke; S R Tzipori; J A Craven
Journal:  Vet Microbiol       Date:  1986-02       Impact factor: 3.293

9.  Efficacy of enteric-coated protease in preventing attachment of enterotoxigenic Escherichia coli and diarrheal disease in the RITARD model.

Authors:  T L Mynott; D S Chandler; R K Luke
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

10.  The distribution and stability of Escherichia coli K88 receptor in the gastrointestinal tract of the pig.

Authors:  D S Chandler; T L Mynott; R K Luke; J A Craven
Journal:  Vet Microbiol       Date:  1994-01       Impact factor: 3.293

View more
  13 in total

1.  Effect of bromelain on milk yield, milk composition and mammary health in dairy goats.

Authors:  A Contreras; M J Paape; R H Miller; J C Corrales; C Luengo; A Sánchez
Journal:  Trop Anim Health Prod       Date:  2008-07-27       Impact factor: 1.559

Review 2.  Animal Enterotoxigenic Escherichia coli.

Authors:  J Daniel Dubreuil; Richard E Isaacson; Dieter M Schifferli
Journal:  EcoSal Plus       Date:  2016-10

3.  Potential role of bromelain in clinical and therapeutic applications.

Authors:  Vidhya Rathnavelu; Noorjahan Banu Alitheen; Subramaniam Sohila; Samikannu Kanagesan; Rajendran Ramesh
Journal:  Biomed Rep       Date:  2016-07-18

4.  Proteolytic inhibition of Salmonella enterica serovar typhimurium-induced activation of the mitogen-activated protein kinases ERK and JNK in cultured human intestinal cells.

Authors:  Tracey L Mynott; Ben Crossett; S Radhika Prathalingam
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

Review 5.  Small bowel review: normal physiology part 1.

Authors:  A B Thomson; M Keelan; A Thiesen; M T Clandinin; M Ropeleski; G E Wild
Journal:  Dig Dis Sci       Date:  2001-12       Impact factor: 3.199

6.  Bromelain treatment decreases secretion of pro-inflammatory cytokines and chemokines by colon biopsies in vitro.

Authors:  Jane E Onken; Paula K Greer; Brian Calingaert; Laura P Hale
Journal:  Clin Immunol       Date:  2007-12-21       Impact factor: 3.969

7.  Effects of canned pineapple consumption on nutritional status, immunomodulation, and physical health of selected school children.

Authors:  Mavil May C Cervo; Luisito O Llido; Erniel B Barrios; Leonora N Panlasigui
Journal:  J Nutr Metab       Date:  2014-11-20

8.  In vitro Evaluation of Antibacterial Efficacy of Pineapple Extract (Bromelain) on Periodontal Pathogens.

Authors:  N C Praveen; A Rajesh; Manish Madan; Vishwajit Rampratap Chaurasia; Neel V Hiremath; Akanksha Manmohan Sharma
Journal:  J Int Oral Health       Date:  2014-09

9.  Lysozyme improves gut performance and protects against enterotoxigenic Escherichia coli infection in neonatal piglets.

Authors:  Guangping Huang; Xiangqing Li; Dan Lu; Shen Liu; Xun Suo; Qiuyan Li; Ning Li
Journal:  Vet Res       Date:  2018-02-20       Impact factor: 3.683

10.  Properties and therapeutic application of bromelain: a review.

Authors:  Rajendra Pavan; Sapna Jain; Ajay Kumar
Journal:  Biotechnol Res Int       Date:  2012-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.